Search research articles
Contact Us
Filters
Showing results (41-50 of 181) with videos related to
Page
of 19
Sort By:
Leukemia & Lymphoma
|
February 28, 2007
A pilot study of imatinib, low-dose cytarabine and idarubicin for patients with chronic myeloid leukemia in myeloid blast phase
Alfonso Quintás-Cardama, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Blood
|
February 22, 2003
Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome
Jorge Cortes, Patricia Ault, Charles Koller, et al.
Clinical Pharmacology and Therapeutics
|
August 5, 2020
Integrated Mechanistic Model of Minimal Residual Disease Kinetics With Venetoclax Therapy in Chronic Lymphocytic Leukemia
Sathej Gopalakrishnan, William Wierda, Brenda Chyla, et al.
Journal of Clinical Pathology
|
November 24, 2018
Distinguishing thymoma from T-lymphoblastic leukaemia/lymphoma: a case-based evaluation
Prajwal Boddu, Beenu Thakral, Ahmed Alhuraiji, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 8, 2014
Lenalidomide-induced graft-vs.-Leukemia effect in a patient with chronic lymphocytic leukemia who relapsed after allogeneic stem cell transplant
Rohtesh S Mehta, Antonio Di Stasi, Chitra Hosing, et al.
Cancer
|
July 22, 2014
FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia
Preetesh Jain, Hun Ju Lee, Wei Qiao, et al.
British Journal of Haematology
|
June 18, 2010
Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia
Fabio P S Santos, Hagop Kantarjian, Carmen Fava, et al.
Cancer
|
September 19, 2008
Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years
Hagop Kantarjian, Susan O'Brien, Jorge Cortes, et al.
Cancer
|
January 26, 2006
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome
Hagop Kantarjian, Susan O'brien, Jorge Cortes, et al.
Biomed Research International
|
February 6, 2015
Phase II, open label, randomized comparative trial of ondansetron alone versus the combination of ondansetron and aprepitant for the prevention of nausea and vomiting in patients with hematologic malignancies receiving regimens containing high-dose cytarabine
Talha Badar, Jorge Cortes, Gautam Borthakur, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 181) with videos related to
Sort By:
Page
of 19
Leukemia & Lymphoma
|
February 28, 2007
A pilot study of imatinib, low-dose cytarabine and idarubicin for patients with chronic myeloid leukemia in myeloid blast phase
Alfonso Quintás-Cardama, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Blood
|
February 22, 2003
Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome
Jorge Cortes, Patricia Ault, Charles Koller, et al.
Clinical Pharmacology and Therapeutics
|
August 5, 2020
Integrated Mechanistic Model of Minimal Residual Disease Kinetics With Venetoclax Therapy in Chronic Lymphocytic Leukemia
Sathej Gopalakrishnan, William Wierda, Brenda Chyla, et al.
Journal of Clinical Pathology
|
November 24, 2018
Distinguishing thymoma from T-lymphoblastic leukaemia/lymphoma: a case-based evaluation
Prajwal Boddu, Beenu Thakral, Ahmed Alhuraiji, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 8, 2014
Lenalidomide-induced graft-vs.-Leukemia effect in a patient with chronic lymphocytic leukemia who relapsed after allogeneic stem cell transplant
Rohtesh S Mehta, Antonio Di Stasi, Chitra Hosing, et al.
Cancer
|
July 22, 2014
FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia
Preetesh Jain, Hun Ju Lee, Wei Qiao, et al.
British Journal of Haematology
|
June 18, 2010
Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia
Fabio P S Santos, Hagop Kantarjian, Carmen Fava, et al.
Cancer
|
September 19, 2008
Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years
Hagop Kantarjian, Susan O'Brien, Jorge Cortes, et al.
Cancer
|
January 26, 2006
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome
Hagop Kantarjian, Susan O'brien, Jorge Cortes, et al.
Biomed Research International
|
February 6, 2015
Phase II, open label, randomized comparative trial of ondansetron alone versus the combination of ondansetron and aprepitant for the prevention of nausea and vomiting in patients with hematologic malignancies receiving regimens containing high-dose cytarabine
Talha Badar, Jorge Cortes, Gautam Borthakur, et al.
Page
of 19